Cardiovascular and subjective effects of intravenous cocaine administration in humans. 1976

M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman

Nine volunteer subjects were tested with intravenously administered cocaine hydrochloride in doses ranging from 4 to 32 mg, as well as 10 mg of dextroamphetamine sulfate. Measures of cardiovascular and subjective effects were made. Generally parallel dose-effect functions were obtained for heart rate, blood pressure, Addiction Research Center Inventory scores, Profile of Mood Scales, and subject ratings. A substantial effect on each of these variables was recorded after 8 mg of cocaine. The increase continued and peaked at approximately 16 mg after which it usually leveled off. Ten milligrams of dextroamphetamine generally had an effect comparable to 8 to 16 mg of cocaine.

UI MeSH Term Description Entries
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004644 Emotions Those affective states which can be experienced and have arousing and motivational properties. Feelings,Regret,Emotion,Feeling,Regrets
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
April 1991, The Journal of pharmacology and experimental therapeutics,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
May 1992, The Journal of pharmacology and experimental therapeutics,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
January 1991, Psychopharmacology,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
December 1989, Pharmacology, biochemistry, and behavior,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
January 1989, NIDA research monograph,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
March 2006, Drug and alcohol dependence,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
May 2004, Pharmacology, biochemistry, and behavior,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
April 1992, British journal of addiction,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
November 2001, Drug and alcohol dependence,
M W Fischman, and C R Schuster, and L Resnekov, and J F Shick, and N A Krasnegor, and W Fennell, and D X Freedman
August 2001, Psychopharmacology,
Copied contents to your clipboard!